Showing 651-660 of 4484 results for "".
Camera Ready: How to Work with Media
https://practicaldermatology.com/topics/practice-management/camera-ready-how-to-work-with-media/18661/Hilary Baldwin, MD talks to host Neal Bhatia, MD about working with the media on this edition of Derm Insider. Her number one piece of advice: Make sure you know what you're doing and that you should be doing it, and know when to pass. If you do an interview, be passionate and have two to three keySpecial Considerations in Psoriasis Treatment
https://practicaldermatology.com/topics/psoriasis/special-considerations-in-psoriasis-treatment/18686/Steven R. Feldman, MD, PhD sits down with DermTube Journal Club host Joshua Zeichner, MD to talk about special treatment considerations for psoriasis. He offers tips for treating pregnant patients with psoriasis and the safety of certain topicals and biologics for this population. Dr. Feldman discusDermWireTV: Latest on Galderma, Eczema Awareness, Hacking Derm, and More
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-latest-on-galderma-eczema-awareness-hacking-derm-and-more/19675/In this week’s edition: Galderma’s Aklief (trifarotene) topical cream is now approved for acne. Sandra Johnson, MD weighs in. Supported by Sanofi and Regeneron in partnership with the National Eczema Association, the Understand AD Squad includes dermatologist Mercedes Gonzalez, MD, who discusses herAdvocating for the Specialty and Patient Safety
https://practicaldermatology.com/topics/practice-management/advocating-for-the-specialty-and-patient-safety/18702/George J. Hruza, MD, Past President of the American Society for Dermatologic Surgery (ASDS), sat down with DermTube Journal Club Host Nancy J. Samolitis, MD to discuss the importance of getting involved with organizations like the ASDS and the American Academy of Dermatology Association to advocateActinic Keratosis: Therapy Overview
https://practicaldermatology.com/topics/skin-cancer-photoprotection/actinic-keratosis-therapy-overview/19732/Joel Cohen, MD interviews George Martin, MD about the latest developments in actinic keratosis. Dr. Martin said he is eagerly awaiting regulatory review of tirbanibulin, which showed promising results in clinical trials. The two also discuss practical tips and nuances of using 5FU in practice. *Be sFull-Face Rejuvenation: Surface to Shape
https://practicaldermatology.com/topics/general-topics/full-face-rejuvenation-surface-to-shape/18576/DermTube Journal Club host Nancy Samolitis, MD interviews Sabine Zenker, MD about her approach to full-face rejuvenation to address patients' concerns about changes on the surface of their skin to the structure. Dr. Zenker says facial rejuvenation needs to address skin quality, wrinkles and rhytids,Acne Update: A Review of New Guidelines, Treatment Advances, and Drugs in the Pipeline
https://practicaldermatology.com/topics/general-topics/acne-update-a-review-of-new-guidelines-treatment-advances-and-drugs-in-the-pipeline/18773/Linda Stein Gold, MD talks to DermTube Journal Club Host Joshua Zeichner, MD about the new acne treatment guidelines recently published in the Journal of the American Academy of Dermatology. She discusses the process of developing the guidelines and highlights some of what's new, such as new, limiteGold's Standards: Nashville's Laser Guru on Best Practices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/gold-s-standards-nashville-s-laser-guru-on-best-practices/18867/When a third of your practice is dedicated to energy-based devices, it's important to find the best solutions for your patient flow. In this edition of Best Practices, Joel L. Cohen, MD talks to Michael H. Gold, MD about his approach to adoption and promotion of energy-based devices. Dr. Gold discusGalderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million dDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)